A summary of the FDA-NIMH-MATRICS workshop on clinical trial design for neurocognitive drugs for schizophrenia

Robert W. Buchanan, Miriam Davis, Donald Goff, Michael F. Green, Richard S.E. Keefe, Andrew C. Leon, Keith H. Nuechterlein, Thomas Laughren, Robert Levin, Ellen Stover, Wayne Fenton, Steve R. Marder

Research output: Contribution to journalArticlepeer-review

401 Scopus citations

Fingerprint

Dive into the research topics of 'A summary of the FDA-NIMH-MATRICS workshop on clinical trial design for neurocognitive drugs for schizophrenia'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science

Neuroscience